News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,242 Results
Type
Article (34132)
Company Profile (26)
Press Release (158084)
Section
Business (56914)
Career Advice (410)
Deals (4348)
Drug Delivery (19)
Drug Development (26130)
Employer Resources (41)
FDA (3750)
Job Trends (3681)
News (90451)
Policy (6411)
Tag
Academia (2436)
Alliances (12175)
Alzheimer's disease (490)
Approvals (3737)
Artificial intelligence (35)
Bankruptcy (26)
Best Places to Work (3047)
Breast cancer (36)
Cancer (342)
Cardiovascular disease (38)
Career advice (375)
CAR-T (23)
Cell therapy (72)
Clinical research (19775)
Collaboration (93)
COVID-19 (1266)
C-suite (67)
Data (427)
Diabetes (32)
Diagnostics (1748)
Earnings (7572)
Employer resources (36)
Events (22191)
Executive appointments (206)
FDA (3861)
Funding (100)
Gene therapy (49)
GLP-1 (136)
Government (1237)
Healthcare (6018)
Infectious disease (1285)
Inflammatory bowel disease (32)
Interviews (47)
IPO (1845)
Job creations (709)
Job search strategy (347)
Layoffs (47)
Legal (1487)
Lung cancer (42)
Manufacturing (26)
Medical device (3282)
Medtech (3283)
Mergers & acquisitions (2530)
Metabolic disorders (88)
Neuroscience (553)
NextGen Class of 2024 (2034)
Non-profit (2452)
Northern California (433)
Obesity (41)
Opinion (36)
People (33222)
Phase I (6213)
Phase II (8922)
Phase III (6115)
Pipeline (99)
Postmarket research (1116)
Preclinical (3414)
Press Release (25)
Radiopharmaceuticals (69)
Rare diseases (57)
Real estate (1516)
Regulatory (4018)
Research institute (1404)
Resumes & cover letters (29)
Southern California (315)
Startups (1241)
United States (3290)
Vaccines (198)
Weight loss (23)
Date
Today (1)
Last 7 days (196)
Last 30 days (847)
Last 365 days (8599)
2024 (7810)
2023 (10176)
2022 (12548)
2021 (14338)
2020 (14289)
2019 (14552)
2018 (11085)
2017 (9760)
2016 (10025)
2015 (11475)
2014 (8654)
2013 (8331)
2012 (8459)
2011 (8612)
2010 (7839)
Location
Africa (286)
Arizona (38)
Asia (10817)
Australia (2699)
California (846)
Canada (302)
China (64)
Colorado (39)
Connecticut (45)
Europe (28954)
Florida (90)
Georgia (31)
Illinois (101)
Indiana (44)
Japan (21)
Maryland (97)
Massachusetts (526)
Michigan (28)
Minnesota (46)
New Jersey (214)
New York (250)
North Carolina (215)
Northern California (433)
Ohio (49)
Pennsylvania (177)
South America (307)
Southern California (315)
Texas (120)
Utah (21)
Washington D.C. (28)
Washington State (195)
192,242 Results for "george washington university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Interventional DiviTum(R) TKa Trial Launches at Washington University
Biovica, active in blood-based cancer monitoring, announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis.
March 13, 2024
·
2 min read
Press Releases
Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides
November 22, 2024
·
3 min read
Biotech Bay
Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
Guardant Health, Inc. (Nasdaq: GH) announced its research collaborators from Washington University’s Siteman Cancer Center will lead an oral presentation today at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting highlighting the potential role of liquid biopsy in addressing racial inequities in enrollment in clinical trials and in the use of targeted therapies for advanced breast cancer.
June 3, 2024
·
5 min read
Job Trends
5 Top Companies Hiring in the Washington, D.C., Area
Looking for a biopharma job in or near Washington, D.C.? Check out these five top companies hiring life sciences professionals like you.
June 26, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024
November 15, 2024
·
7 min read
Business
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
Calidi Biotherapeutics, Inc. today announced the appointment of Dr. George E. Peoples, MD, FACS, to the company’s Board of Directors, effective July 1, 2024.
June 27, 2024
·
4 min read
Press Releases
Augurex to Present Axial Spondyloarthritis Data and Exhibit at ACR Convergence 2024 in Washington, DC
November 7, 2024
·
3 min read
Biotech Bay
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Vaxart, Inc. announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine Congress Washington 2024 in Washington, D.C. on Wednesday, April 3, 2024.
March 27, 2024
·
1 min read
Business
George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director
George Medicines announces the appointment of Mark Mallon as its new Chief Executive Officer and Board Director, effective immediately.
April 29, 2024
·
3 min read
Business
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
Nkarta, Inc., a clinical-stage biopharmaceutical company developing engineered natural killer cell therapies announced that translational immunology expert George Vratsanos, M.D., FACR, is joining its board of directors.
June 13, 2024
·
5 min read
1 of 19,225
Next